Login to Your Account



Washington Roundup

Supremes to Hear Arguments on 'Fraud-on-the-Market' Claims

By Marie Powers
Staff Writer

Monday, November 5, 2012
The Supreme Court is expected to hear oral arguments in Amgen Inc. v. Connecticut Retirement Plans and Trust Funds, in which the big biotech is appealing a decision from the Court of Appeals for the Ninth Circuit that upheld a federal district court's refusal to hear evidence rebutting fraud-on-the-market claims involving erythropoietins before it certified a class in the shareholder lawsuit.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription